US$ 29.66
semaglutide coming off shortage list As of February 21, 2025, the FDA updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A FDA's GLP-1 decision kicks off
Description
Get Answers Now

Injection site reactions (redness, itching, or swelling) occur in approximately 0.1-1.7% of patients according to prescribing information

A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide With Other GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Previously Receiving Basal Insuli
The medication may damage the developing baby if it enters the breastmilk, according to limited human data

Follow-up ranged from 12 months to 9 years

Finally got in touch and discontinued but was not able to return an unopened package